Stock Earnings

Question 1

How did FOLD's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for Amicus Therapeutics Inc is $0.06, beating expectations of $0.03.

Question 2

How did Amicus Therapeutics Inc FOLD's revenue perform in the last quarter?

Accepted Answer

Amicus Therapeutics Inc revenue for the last quarter is $0.06

Question 3

What is the revenue estimate for Amicus Therapeutics Inc?

Accepted Answer

According to 11 of Wall street analyst, the revenue estimate of Amicus Therapeutics Inc range from $193.2M to $170.83M

Question 4

What's the earning quality score for Amicus Therapeutics Inc?

Accepted Answer

Amicus Therapeutics Inc has a earning quality score of B+/56.918335. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does Amicus Therapeutics Inc report earnings?

Accepted Answer

Amicus Therapeutics Inc next earnings report is expected in 2026-02-02

Question 6

What are Amicus Therapeutics Inc's expected earnings?

Accepted Answer

Amicus Therapeutics Inc expected earnings is $169.02M, according to wall-street analysts.

Question 7

Did Amicus Therapeutics Inc beat earnings expectations?

Accepted Answer

Amicus Therapeutics Inc recent earnings of $169.06M beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$0.03	$0.06	+100.0%	BEAT
Q2 '25	$-0.12	$-0.07	-41.66%	MISSED
Q1 '25	$-0.05	$-0.07	+40.0%	BEAT
Q4 '24	$0.01	$0.05	+400.0%	BEAT
Q3 '24	$--	$-0.02	--	--

Amicus Therapeutics Inc (FOLD) Price

FOLD Stock Price Chart

Latest Earnings Results: Q3 '25

Historical Earnings

Earnings FAQ